Quantitation Of G0 And G1 Phase Cells In Primary Carcinomas ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Subject: 1 selected item: 1991836 - PubMed To: From: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

American Society for Clinical Investigation Free PMC article Full text links

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel Display options Display options Format AbstractPubMedPMID

Share

• Permalink Copy

Page navigation

• Title & authors
• Abstract
• Similar articles
• Cited by
• References
• Publication types
• MeSH terms
• Substances
• LinkOut - more resources

Title & authors Abstract Similar articles Cited by References Publication types MeSH terms Substances LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Human cancers have an apparent low growth fraction, the bulk of cells presumed to being out of cycle in a G0 quiescent state due to the inability in the past to distinguish G0 from G1 cells. The allosteric M1 subunit of ribonucleotide reductase (M1-RR) is constitutively expressed by cycling cells (i.e., G1, S, G2-M). It is acquired during transition from G0 to G1, lost during exit to G0 and thus distinguishes G0 from G1 cells. To estimate the proportion of G0 and G1 cells in primary human breast (n = 5) and colorectal (n = 12) adenocarcinomas, we used both analytical DNA flow cytometry (ADFC) and immunoperoxidase staining of sections with the monoclonal antibody to M1-RR (MAb M1-RR). ADFC of fresh tumors revealed a low percentage of cells in the S phase (4.0 +/- 3.4%) but immunoperoxidase staining for M1-RR revealed an unexpectedly high proportion of positive cells (52.4 +/- 12.7%) in the G1, S, G2-M phases indicating a high G1 content of primary human tumors. Thus, human cancers are blocked in transition in G1 and are not predominantly in a G0 or quiescent differentiated state. This block was interpreted to mean that human cancers are responding to putative regulatory events at a restriction point in the G1 phase, such as relative growth factor deficiency, density inhibition, antiproliferative cytokines, or gene products. Using flow cytometry for both DNA and M1-RR content we found that human colon cancer cell lines arrest in the G1 but not G0 phase upon serum deprivation or density inhibition. Similarly, human breast cancer cell lines are arrested in G1 but not G0 phase by medroxyprogesterone acetate (MPA) or tamoxifen exposure. These findings match our in situ observations, and support the concept of a restriction point block in primary human tumors.

PubMed Disclaimer

Similar articles

• Bivariate flow cytometric analysis of DNA content versus immunopositivity for ribonucleotide reductase M1 subunit in the cell cycle. Mangiarotti R, Bottone MG, Danova M, Pellicciari C. Mangiarotti R, et al. Cytometry. 1998 Jun 1;32(2):78-85. doi: 10.1002/(sici)1097-0320(19980601)32:23.0.co;2-a. Cytometry. 1998. PMID: 9627220
• Cytometry of cyclin proteins. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F. Darzynkiewicz Z, et al. Cytometry. 1996 Sep 1;25(1):1-13. doi: 10.1002/(SICI)1097-0320(19960901)25:13.0.CO;2-N. Cytometry. 1996. PMID: 8875049 Review.
• Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Sutherland RL, Hall RE, Taylor IW. Sutherland RL, et al. Cancer Res. 1983 Sep;43(9):3998-4006. Cancer Res. 1983. PMID: 6871841
• Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Mann GJ, Musgrove EA, Fox RM, Thelander L. Mann GJ, et al. Cancer Res. 1988 Sep 15;48(18):5151-6. Cancer Res. 1988. PMID: 3044582
• Ribonucleotide reductase--new twists in an old tale. Whitfield JF, Sikorska M, Youdale T, Brewer L, Richards R, Walker PR. Whitfield JF, et al. Adv Enzyme Regul. 1989;28:113-23. doi: 10.1016/0065-2571(89)90067-8. Adv Enzyme Regul. 1989. PMID: 2696342 Review.

See all similar articles

Cited by

• E4orf1: The triple agent of adenovirus - Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy. Göttig L, Schreiner S. Göttig L, et al. Tumour Virus Res. 2024 Jun;17:200277. doi: 10.1016/j.tvr.2024.200277. Epub 2024 Feb 28. Tumour Virus Res. 2024. PMID: 38428735 Free PMC article. Review.
• Exploring the tumor micro-environment in primary and metastatic tumors of different ovarian cancer histotypes. Xie B, Olalekan S, Back R, Ashitey NA, Eckart H, Basu A. Xie B, et al. Front Cell Dev Biol. 2024 Jan 24;11:1297219. doi: 10.3389/fcell.2023.1297219. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38328306 Free PMC article.
• PRE-CLINICAL AND CLINICAL VALIDATION OF AN ANTI-CANCER MODALITY THAT ABLATES REFRACTORY, LOW GROWTH FRACTION TUMORS. Sorscher EJ, Hong JS, Parker WB. Sorscher EJ, et al. Trans Am Clin Climatol Assoc. 2016;127:59-70. Trans Am Clin Climatol Assoc. 2016. PMID: 28066038 Free PMC article.
• Activated lymphocytes as a metabolic model for carcinogenesis. Macintyre AN, Rathmell JC. Macintyre AN, et al. Cancer Metab. 2013 Jan 23;1(1):5. doi: 10.1186/2049-3002-1-5. Cancer Metab. 2013. PMID: 24280044 Free PMC article.
• In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase. Sorscher EJ, Hong JS, Allan PW, Waud WR, Parker WB. Sorscher EJ, et al. Cancer Chemother Pharmacol. 2012 Aug;70(2):321-9. doi: 10.1007/s00280-012-1908-9. Epub 2012 Jul 4. Cancer Chemother Pharmacol. 2012. PMID: 22760227 Free PMC article.

See all "Cited by" articles

References

1. 1. Cancer Treat Rep. 1978 Aug;62(8):1117-33 - PubMed
2. 1. Cancer Res. 1990 Jul 15;50(14):4382-7 - PubMed
3. 1. Am J Anat. 1971 May;131(1):73-99 - PubMed
4. 1. Am J Dig Dis. 1964 Nov;9:760-3 - PubMed
5. 1. Int Rev Cytol. 1987;100:93-128 - PubMed

Show all 41 references

Publication types

• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Adenocarcinoma / pathology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Antibodies, Monoclonal Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Breast Neoplasms / pathology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cell Cycle Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Colorectal Neoplasms / pathology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• DNA, Neoplasm / analysis Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Flow Cytometry Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Immunohistochemistry Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Interphase* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Intestinal Mucosa / physiology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Ribonucleotide Reductases / immunology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tumor Cells, Cultured / pathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Antibodies, Monoclonal Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• DNA, Neoplasm Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Ribonucleotide Reductases Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • American Society for Clinical Investigation
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal

Full text links [x] American Society for Clinical Investigation Free PMC article [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.